Skip Navigation

European Journal of Heart Failure 2007 9(12):1196-1204; doi:10.1016/j.ejheart.2007.10.001
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Murphy, N. F.
Right arrow Articles by McDonald, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murphy, N. F.
Right arrow Articles by McDonald, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 European Society of Cardiology

Improvement but no cure of left ventricular systolic dysfunction in treated heart failure patients

Niamh F. Murphy, Christina O'Loughlin, Mark Ledwidge, Dermot McCaffrey and Kenneth McDonald*

Heart Failure Unit, Department of Cardiology, St Vincent's University Hospital, and University College Dublin Dublin 4, Ireland

* Corresponding author. Department of Cardiology, St Vincent's University Hospital Elm Park, Dublin 4, Ireland. Tel.: +353 1 2845735; fax: +353 1 2304639. kenneth.mcdonald{at}ucd.ie (K. McDonald).


   Abstract

Background: Recent advances in pharmacological and pacemaker-based treatments for heart failure (HF) have brought about significant improvements in left ventricular function.

Aims: To identify the proportion of treated systolic HF patients in whom left ventricular systolic function improves and/or returns to normal.

Methods: This was a retrospective analysis of 221 HF patients. Improvement in left ventricular function was defined as an improvement in ejection fraction (LVEF) of ≥10% on echocardiography. Return to normal was defined as an improvement of LVEF to ≥50% and a reduction in left ventricular end diastolic diameter to ≤55 mm. Changes in BNP were also recorded.

Results: Improvement in LVEF was observed in 44.3% of patients and return to normal systolic function in 10.9%, only 2.3% had both a return to normal echocardiographic parameters and a BNP<100 pg/ml. A higher percentage of the improved group were on target doses of β-blockers (p=0.004). Baseline BNP was not a predictor of improvement. There was a trend towards a reduction in HF readmissions in the improved group (p=0.07) but no difference in the risk of death or all-cause readmission.

Conclusion: While a substantial proportion of treated HF patients have an improvement in left ventricular function over time, only a small proportion return to normal dimensions and LVEF, underlining the permanent nature of ventricular damage in the vast majority of patients.

Key Words: Heart failure • Left ventricular function • Echocardiography • B-type natriuretic peptide • Improvement • Return to normal

Received August 30, 2007; Accepted October 3, 2007


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.